Interim results of new device for treatment resistant hypertension - PACE-CME

Interim results of new device for treatment resistant hypertension

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Careful implementation of PCSK9 inhibitors in clinical practice
Careful implementation of PCSK9 inhibitors in clinical practice
CSI 2016 ESC
Careful implementation of PCSK9 inhibitors in clinical practice
- Prof. dr. Terje Pedersen
Would lower than the current ApoB targets be more useful for clinical decision-making?
Would lower than the current ApoB targets be more useful for clinical decision-making?
CSI 2016 ESC
Would lower than the current ApoB targets be more useful for clinical decision-making?
- Seth Shay Martin, MD
A minority of FH patients is identified and labeled as such, which impacts treatment
A minority of FH patients is identified and labeled as such, which impacts treatment
CSI 2016 ESC
A minority of FH patients is identified and labeled as such, which impacts treatment
- Prof Kausik Ray
Understanding why patients do not take their medication and stimulating adherence
Understanding why patients do not take their medication and stimulating adherence
CSI 2016 ESC
Understanding why patients do not take their medication and stimulating adherence
- Prof. Robert Horne